Company Filing History:
2 out of 61 
2 out of 12 Years Active: 2025
Title: Marta Struga: Innovator in Neurological Treatments
Introduction
Marta Struga is a prominent inventor based in Milanowek, Poland. She has made significant contributions to the field of neurological treatments, particularly through her innovative work on modified amino acid derivatives. With a total of 2 patents, her research focuses on addressing neurological diseases and psychiatric disorders.
Latest Patents
Marta Struga's latest patents include "Modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders." The specific compounds, 2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2-oxopyrrolidin-1-yl)propanamide derivatives with R-configuration at the stereogenic center, have shown broad-spectrum protective activity in animal models. These compounds effectively address issues such as epileptic seizures, pain, depression, and anxiety while being devoid of undesirable sedative effects. Additionally, the disclosed derivatives have demonstrated neuroprotective effects in both in vitro and in vivo studies.
Career Highlights
Marta has worked at notable institutions, including Jagiellonian University and the Medical University of Warsaw. Her academic and research endeavors have significantly advanced the understanding of neurological treatments and their applications.
Collaborations
Marta has collaborated with esteemed colleagues, including Krzysztof Kaminski and Michal Abram, further enhancing her research and contributions to the field.
Conclusion
Marta Struga's innovative work in developing modified amino acid derivatives showcases her commitment to improving treatments for neurological and psychiatric disorders. Her contributions are paving the way for future advancements in this critical area of medicine.